Profiling gene expression of whole cytochrome P450 superfamily in human bronchial and peripheral lung tissues: Differential expression in non-small cell lung cancers

Biochimie

Volumn 92, Issue 3, 2010, Pages 292-306

  Leclerc, Julie ^a   Tournel, Gilles ^a   Courcot Ngoubo Ngangue, Elisabeth ^a   Pottier, Nicolas ^a   Lafitte, Jean Jacques ^b   Jaillard, Sophie ^c   Mensier, Eric ^c   Lhermitte, Michel ^a   Broly, Franck ^a   Lo Guidice, Jean Marc ^a  

^a France Institut Pasteur de Lille   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Polyclinique du Bois   (France)

Author keywords

Cytochrome P450; Gene expression; Lung; Non small cell lung cancer; TaqMan low density array

Indexed keywords

ALDOSTERONE SYNTHASE; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); COMPLEMENTARY DNA; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 26A1; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2C18; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 2J2;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 77649273737     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.12.007     Document Type: Article

References (124)

1. Castell J.V., Donato M.T., Gomez-Lechon M.J. Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach. Exp. Toxicol. Pathol. 2005, 57(Suppl. 1):189-204.
2. Nebert D.W., Dalton T.P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat. Rev. Cancer 2006, 6:947-960.
3. Liu G., Zhou W., Christiani D.C. Molecular epidemiology of non-small cell lung cancer. Semin. Respir. Crit. Care Med. 2005, 26:265-272.
4. Michael M., Doherty M.M. Tumoral drug metabolism: overview and its implications for cancer therapy. J. Clin. Oncol. 2005, 23:205-229.
5. Stark K., Wu Z.L., Bartleson C.J., Guengerich F.P. mRNA distribution and heterologous expression of orphan cytochrome P450 20A1. Drug Metab. Dispos 2008, 36:1930-1937.
6. Xi J., Yang Z. Expression of RALDHs (ALDH1As) and CYP26s in human tissues and during the neural differentiation of P19 embryonal carcinoma stem cell. Gene Expr. Patterns 2008, 8:438-442.
7. Bieche I., Narjoz C., Asselah T., et al. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet. Genomics 2007, 17:731-742.
8. Choudhary D., Jansson I., Stoilov I., Sarfarazi M., Schenkman J.B. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch. Biochem. Biophys. 2005, 436:50-61.
9. Nishimura M., Yaguti H., Yoshitsugu H., Naito S., Satoh T. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 2003, 123:369-375.
10. Spivack S.D., Hurteau G.J., Fasco M.J., Kaminsky L.S. Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin. Cancer Res. 2003, 9:6002-6011.
11. Hukkanen J., Pelkonen O., Hakkola J., Raunio H. Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit. Rev. Toxicol. 2002, 32:391-411.
12. Bylund J., Bylund M., Oliw E.H. cDna cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem. Biophys. Res. Commun. 2001, 280:892-897.
13. Cui X., Nelson D.R., Strobel H.W. A novel human cytochrome P450 4F isoform (CYP4F11): cDNA cloning, expression, and genomic structural characterization. Genomics 2000, 68:161-166.
14. Su T., Bao Z., Zhang Q.Y., Smith T.J., Hong J.Y., Ding X. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 2000, 60:5074-5079.
15. Klose T.S., Blaisdell J.A., Goldstein J.A. Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J. Biochem. Mol. Toxicol. 1999, 13:289-295.
16. Raunio H., Hakkola J., Hukkanen J., et al. Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue. Exp. Toxicol. Pathol. 1999, 51:412-417.
17. Shimada T., Yamazaki H., Mimura M., et al. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab. Dispos. 1996, 24:515-522.
18. Czerwinski M., McLemore T.L., Gelboin H.V., Gonzalez F.J. Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res. 1994, 54:1085-1091.
19. McLemore T.L., Adelberg S., Liu M.C., et al. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl. Cancer Inst. 1990, 82:1333-1339.
20. Oyama T., Sugio K., Isse T., et al. Expression of cytochrome P450 in non-small cell lung cancer. Front. Biosci. 2008, 13:5787-5793.
21. Kreutzer M., Fauti T., Kaddatz K., et al. Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells. Oncol. Rep. 2007, 18:497-501.
22. Oyama T., Sugio K., Uramoto H., et al. Cytochrome P450 expression (CYP) in non-small cell lung cancer. Front. Biosci. 2007, 12:2299-2308.
23. Anderson M.G., Nakane M., Ruan X., Kroeger P.E., Wu-Wong J.R. Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother. Pharmacol. 2006, 57:234-240.
24. Enayetallah A.E., French R.A., Grant D.F. Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms. J. Mol. Histol. 2006, 37:133-141.
25. Karlgren M., Gomez A., Stark K., et al. Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1. Biochem. Biophys. Res. Commun. 2006, 341:451-458.
26. Parise R.A., Egorin M.J., Kanterewicz B., et al. CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer. Int. J. Cancer 2006, 119:1819-1828.
27. Zhu L.R., Thomas P.E., Lu G., et al. CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody. Drug Metab. Dispos. 2006, 34:1672-1676.
28. Jiang J.G., Chen C.L., Card J.W., et al. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res. 2005, 65:4707-4715.
29. Saarikoski S.T., Wikman H.A., Smith G., Wolff C.H., Husgafvel-Pursiainen K. Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry. J. Histochem. Cytochem. 2005, 53:549-556.
30. Nana-Sinkam P., Golpon H., Keith R.L., et al. Prostacyclin in human non-small cell lung cancers. Chest 2004, 125:141S.
31. Rieger M.A., Ebner R., Bell D.R., et al. Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma. Cancer Res. 2004, 64:2357-2364.
32. Ermert L., Dierkes C., Ermert M. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors. Clin. Cancer Res. 2003, 9:1604-1610.
33. Murray G.I., Taylor M.C., McFadyen M.C., et al. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res. 1997, 57:3026-3031.
34. Kivisto K.T., Linder A., Friedel G., et al. Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue. Virchows Arch. 1995, 426:243-247.
35. Saviozzi S., Cordero F., Lo Iacono M., Novello S., Scagliotti G.V., Calogero R.A. Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer. BMC Cancer 2006, 6:200.
36. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
37. Pavek P., Dvorak Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr. Drug Metab. 2008, 9:129-143.
38. Rodriguez-Antona C., Donato M.T., Pareja E., Gomez-Lechon M.J., Castell J.V. Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. Arch. Biochem. Biophys. 2001, 393:308-315.
39. Thum T., Erpenbeck V.J., Moeller J., Hohlfeld J.M., Krug N., Borlak J. Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ. Health Perspect. 2006, 114:1655-1661.
40. Willey J.C., Coy E.L., Frampton M.W., et al. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am. J. Respir. Cell Mol. Biol. 1997, 17:114-124.
41. Bernauer U., Heinrich-Hirsch B., Tonnies M., Peter-Matthias W., Gundert-Remy U. Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination. Toxicol. Lett. 2006, 164:278-288.
42. Wei C., Caccavale R.J., Kehoe J.J., Thomas P.E., Iba M.M. CYP1A2 is expressed along with CYP1A1 in the human lung. Cancer Lett. 2001, 171:113-120.
43. Mace K., Bowman E.D., Vautravers P., Shields P.G., Harris C.C., Pfeifer A.M. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer 1998, 34:914-920.
44. Shimada T., Hayes C.L., Yamazaki H., et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 1996, 56:2979-2984.
45. Shah P.P., Singh A.P., Singh M., et al. Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer. Mutat. Res. 2008, 643:4-10.
46. Xu C., Goodz S., Sellers E.M., Tyndale R.F. CYP2A6 genetic variation and potential consequences. Adv. Drug Deliv. Rev. 2002, 54:1245-1256.
47. Yamano S., Tatsuno J., Gonzalez F.J. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 1990, 29:1322-1329.
48. Ding S., Lake B.G., Friedberg T., Wolf C.R. Expression and alternative splicing of the cytochrome P-450 CYP2A7. Biochem. J. 1995, 306(Pt 1):161-166.
49. Willey J.C., Coy E., Brolly C., et al. Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am. J. Respir. Cell Mol. Biol. 1996, 14:262-271.
50. Mori M., Tezuka F., Chiba R., et al. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics. Cancer 1996, 77:665-674.
51. Hukkanen J., Hakkola J., Anttila S., et al. Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes. Mol. Carcinog. 1997, 20:224-230.
52. Spratlin J., Sawyer M.B. Pharmacogenetics of paclitaxel metabolism. Crit. Rev. Oncol. Hematol. 2007, 61:222-229.
53. Rostami-Hodjegan A., Lennard M.S., Woods H.F., Tucker G.T. Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease. Pharmacogenetics 1998, 8:227-238.
54. Bouchardy C., Benhamou S., Dayer P. The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res. 1996, 56:251-253.
55. Caporaso N., Hayes R.B., Dosemeci M., et al. Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res. 1989, 49:3675-3679.
56. Huang Z., Fasco M.J., Spivack S., Kaminsky L.S. Comparisons of CYP2D messenger RNA splice variant profiles in human lung tumors and normal tissues. Cancer Res. 1997, 57:2589-2592.
57. Lo-Guidice J.M., Marez D., Sabbagh N., et al. Evidence for CYP2D6 expression in human lung. Biochem. Biophys. Res. Commun. 1997, 241:79-85.
58. Yamazaki H., Inui Y., Yun C.H., Guengerich F.P., Shimada T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 1992, 13:1789-1794.
59. Lieber C.S. Cytochrome P-4502E1: its physiological and pathological role. Physiol. Rev. 1997, 77:517-544.
60. Gresner P., Gromadzinska J., Wasowicz W. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 2007, 57:1-25.
61. Carr B.A., Wan J., Hines R.N., Yost G.S. Characterization of the human lung CYP2F1 gene and identification of a novel lung-specific binding motif. J. Biol. Chem. 2003, 278:15473-15483.
62. Wan J., Carr B.A., Cutler N.S., Lanza D.L., Hines R.N., Yost G.S. Sp1 and Sp3 regulate basal transcription of the human CYP2F1 gene. Drug Metab. Dispos. 2005, 33:1244-1253.
63. Lanza D.L., Code E., Crespi C.L., Gonzalez F.J., Yost G.S. Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab. Dispos. 1999, 27:798-803.
64. Sheets P.L., Yost G.S., Carlson G.P. Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1. J. Biochem. Mol. Toxicol. 2004, 18:92-99.
65. Nakajima T., Elovaara E., Gonzalez F.J., et al. Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chem. Res. Toxicol. 1994, 7:891-896.
66. Tournel G., Cauffiez C., Billaut-Laden I., et al. Molecular analysis of the CYP2F1 gene: identification of a frequent non-functional allelic variant. Mutat. Res. 2007, 617:79-89.
67. Saarikoski S.T., Rivera S.P., Hankinson O., Husgafvel-Pursiainen K. CYP2S1: a short review. Toxicol. Appl. Pharmacol. 2005, 207:62-69.
68. Karlgren M., Miura S., Ingelman-Sundberg M. Novel extrahepatic cytochrome P450s. Toxicol. Appl. Pharmacol. 2005, 207:57-61.
69. Wheeler C.W., Wrighton S.A., Guenthner T.M. Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem. Pharmacol. 1992, 44:183-187.
70. Kivisto K.T., Fritz P., Linder A., Friedel G., Beaune P., Kroemer H.K. Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochem. Cell Biol. 1995, 103:25-29.
71. Kivisto K.T., Griese E.U., Fritz P., et al. Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours. Naunyn Schmiedebergs Arch. Pharmacol. 1996, 353:207-212.
72. Anttila S., Hukkanen J., Hakkola J., et al. Expression and localization of CYP3A4 and CYP3A5 in human lung. Am. J. Respir. Cell Mol. Biol. 1997, 16:242-249.
73. Piipari R., Savela K., Nurminen T., et al. Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers. Int. J. Cancer 2000, 86:610-616.
74. Smith G.B., Bend J.R., Bedard L.L., Reid K.R., Petsikas D., Massey T.E. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in peripheral human lung microsomes. Drug Metab. Dispos. 2003, 31:1134-1141.
75. Kuehl P., Zhang J., Lin Y., et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 2001, 27:383-391.
76. Miyoshi Y., Ando A., Takamura Y., Taguchi T., Tamaki Y., Noguchi S. Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues. Int. J. Cancer 2002, 97:129-132.
77. Hardwick J.P. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem. Pharmacol. 2008, 75:2263-2275.
78. Imaoka S., Hayashi K., Hiroi T., Yabusaki Y., Kamataki T., Funae Y. A transgenic mouse expressing human CYP4B1 in the liver. Biochem. Biophys. Res. Commun. 2001, 284:757-762.
79. Poch M.T., Cutler N.S., Yost G.S., Hines R.N. Molecular mechanisms regulating human CYP4B1 lung-selective expression. Drug Metab. Dispos 2005, 33:1174-1184.
80. Christmas P., Jones J.P., Patten C.J., et al. Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J. Biol. Chem. 2001, 276:38166-38172.
81. Ding X., Kaminsky L.S. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 2003, 43:149-173.
82. Hsu M.H., Savas U., Griffin K.J., Johnson E.F. Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation. Drug Metab. Rev. 2007, 39:515-538.
83. Kalsotra A., Strobel H.W. Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism. Pharmacol. Ther. 2006, 112:589-611.
84. Cauffiez C., Klinzig F., Rat E., et al. Functional characterization of genetic polymorphisms identified in the human cytochrome P450 4F12 (CYP4F12) promoter region. Biochem. Pharmacol. 2004, 67:2231-2238.
85. Lefevre C., Bouadjar B., Ferrand V., et al. Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum. Mol. Genet. 2006, 15:767-776.
86. Savas U., Hsu M.H., Griffin K.J., Bell D.R., Johnson E.F. Conditional regulation of the human CYP4X1 and CYP4Z1 genes. Arch. Biochem. Biophys. 2005, 436:377-385.
87. Li A., Jiao X., Munier F.L., et al. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am. J. Hum. Genet. 2004, 74:817-826.
88. Bylund J., Zhang C., Harder D.R. Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain. Biochem. Biophys. Res. Commun. 2002, 296:677-684.
89. Al-Anizy M., Horley N.J., Kuo C.W., et al. Cytochrome P450 Cyp4x1 is a major P450 protein in mouse brain. FEBS J. 2006, 273:936-947.
90. Hashizume T., Imaoka S., Mise M., et al. Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J. Pharmacol. Exp. Ther. 2002, 300:298-304.
91. Zeldin D.C., Foley J., Ma J., et al. CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance. Mol. Pharmacol. 1996, 50:1111-1117.
92. Chuang S.S., Helvig C., Taimi M., et al. CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids. J. Biol. Chem. 2004, 279:6305-6314.
93. Karlgren M., Backlund M., Johansson I., Oscarson M., Ingelman-Sundberg M. Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1. Biochem. Biophys. Res. Commun. 2004, 315:679-685.
94. Miyata A., Yokoyama C., Ihara H., et al. Characterization of the human gene (TBXAS1) encoding thromboxane synthase. Eur. J. Biochem. 1994, 224:273-279.
95. Miyata A., Hara S., Yokoyama C., Inoue H., Ullrich V., Tanabe T. Molecular cloning and expression of human prostacyclin synthase. Biochem. Biophys. Res. Commun. 1994, 200:1728-1734.
96. Nusing R., Ullrich V. Immunoquantitation of thromboxane synthase in human tissues. Eicosanoids 1990, 3:175-180.
97. Ermert L., Ermert M., Duncker H.R., Grimminger F., Seeger W. In situ localization and regulation of thromboxane A(2) synthase in normal and LPS-primed lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 278:L744-L753.
98. Pradono P., Tazawa R., Maemondo M., et al. Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res. 2002, 62:63-66.
99. Keith R.L., Miller Y.E., Hudish T.M., et al. Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice. Cancer Res. 2004, 64:5897-5904.
100. Keith R.L., Miller Y.E., Hoshikawa Y., et al. Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. Cancer Res. 2002, 62:734-740.
101. Stearman R.S., Grady M.C., Nana-Sinkam P., Varella-Garcia M., Geraci M.W. Genetic and epigenetic regulation of the human prostacyclin synthase promoter in lung cancer cell lines. Mol. Cancer Res. 2007, 5:295-308.
102. Pikuleva I.A. Cytochrome P450s and cholesterol homeostasis. Pharmacol. Ther. 2006, 112:761-773.
103. Stromstedt M., Rozman D., Waterman M.R. The ubiquitously expressed human CYP51 encodes lanosterol 14 alpha-demethylase, a cytochrome P450 whose expression is regulated by oxysterols. Arch. Biochem. Biophys. 1996, 329:73-81.
104. Souidi M., Dubrac S., Parquet M., Lutton C. Hepatic and extrahepatic sterol 27-hydroxylase: roles in cholesterol and bile acid metabolism and associated diseases. Gastroenterol. Clin. Biol. 2003, 27:100-111.
105. Babiker A., Andersson O., Lindblom D., et al. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. J. Lipid Res. 1999, 40:1417-1425.
106. Babiker A., Andersson O., Lund E., et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 1997, 272:26253-26261.
107. Tang W., Eggertsen G., Chiang J.Y., Norlin M. Estrogen-mediated regulation of CYP7B1: a possible role for controlling DHEA levels in human tissues. J. Steroid Biochem. Mol. Biol. 2006, 100:42-51.
108. Li-Hawkins J., Lund E.G., Bronson A.D., Russell D.W. Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. J. Biol. Chem. 2000, 275:16543-16549.
109. Eggertsen G., Olin M., Andersson U., et al. Molecular cloning and expression of rabbit sterol 12alpha-hydroxylase. J. Biol. Chem. 1996, 271:32269-32275.
110. Jansen R.A., Liu J.C., Crijns A.P., et al. Pharmacotherapeutic potential of novel genes hypermethylated in advanced stage ovarian cancer. AACR Meet. Abstr. 2006, 759-760.
111. Tissandie E., Gueguen Y., Lobaccaro J.M., Aigueperse J., Souidi M. Vitamin D: metabolism, regulation and associated diseases. Med. Sci. (Paris) 2006, 22:1095-1100.
112. Trump D.L., Muindi J., Fakih M., Yu W.D., Johnson C.S. Vitamin D compounds: clinical development as cancer therapy and prevention agents. Anticancer Res. 2006, 26:2551-2556.
113. Wikman H., Nymark P., Vayrynen A., et al. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer. Genes Chromosomes Cancer 2005, 42:193-199.
114. Labrie F. Intracrinology. Mol. Cell Endocrinol. 1991, 78:C113-C118.
115. Weinberg O.K., Marquez-Garban D.C., Fishbein M.C., et al. Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005, 65:11287-11291.
116. Mah V., Seligson D.B., Li A., et al. Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res. 2007, 67:10484-10490.
117. Jetten A.M., Nervi C., Vollberg T.M. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. J. Natl. Cancer Inst. Monogr. 1992, 93-100.
118. Grummer M.A., Zachman R.D. Retinoic acid and dexamethasone affect RAR-beta and surfactant protein C mRNA in the MLE lung cell line. Am. J. Physiol. 1998, 274:L1-L7.
119. Taimi M., Helvig C., Wisniewski J., et al. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J. Biol. Chem. 2004, 279:77-85.
120. Kim S.Y., Adachi H., Koo J.S., Jetten A.M. Induction of the cytochrome P450 gene CYP26 during mucous cell differentiation of normal human tracheobronchial epithelial cells. Mol. Pharmacol. 2000, 58:483-490.
121. Liu T., Bohlken A., Kuljaca S., et al. The retinoid anticancer signal: mechanisms of target gene regulation. Br. J. Cancer 2005, 93:310-318.
122. Yoshioka H., Kasai N., Ikushiro S., et al. Enzymatic properties of human CYP2W1 expressed in Escherichia coli. Biochem. Biophys. Res. Commun. 2006, 345:169-174.
123. Marek C.J., Tucker S.J., Koruth M., Wallace K., Wright M.C. Expression of CYP2S1 in human hepatic stellate cells. FEBS Lett. 2007, 581:781-786.
124. Wu Z.L., Bartleson C.J., Ham A.J., Guengerich F.P. Heterologous expression, purification, and properties of human cytochrome P450 27C1. Arch. Biochem. Biophys. 2006, 445:138-146.